Compare RIV & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIV | NREF |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Real Estate Investment Trusts |
| Sector | Finance | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.6M | 296.5M |
| IPO Year | N/A | N/A |
| Metric | RIV | NREF |
|---|---|---|
| Price | $11.51 | $17.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 65.4K | 62.7K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | 12.85% | ★ 13.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.93 | $12.36 |
| 52 Week High | $12.56 | $16.99 |
| Indicator | RIV | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 71.96 |
| Support Level | $11.28 | $13.73 |
| Resistance Level | $11.84 | N/A |
| Average True Range (ATR) | 0.17 | 0.35 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 21.74 | 96.98 |
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.